Pfizer Inc.PFENYSE
Loading
R&D Expenses Over TimeExpanding
Percentile Rank93
3Y CAGR+1.6%
5Y CAGR+5.0%
Year-over-Year Change
Research and development spending
3Y CAGR
+1.6%/yr
vs +9.4%/yr prior
5Y CAGR
+5.0%/yr
Recent deceleration
Acceleration
-7.9pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $11.98B | +11.5% |
| 2024 | $10.74B | +1.5% |
| 2023 | $10.58B | -7.4% |
| 2022 | $11.43B | -17.4% |
| 2021 | $13.83B | +47.2% |
| 2020 | $9.39B | +12.3% |
| 2019 | $8.36B | +5.0% |
| 2018 | $7.97B | +4.2% |
| 2017 | $7.64B | -2.5% |
| 2016 | $7.84B | - |